So, That's Who CNN Was Busted Partying With in London Last Month
So, That's Why Dallas Police Shot and Killed a Member of Jasmine Crockett's...
Watch Scott Jennings Absolutely Get Under the Skin of This CNN Guest
This Quote From Gov. Stitt Is NOT Good News Regarding Who He'd Pick...
What These Two Girls Are Laughing About Is Beyond Disturbing
A Dissent for the Ages
So, That's How Republicans Just Lost a Long-Held Mayoral Seat By a Single...
The Cuba Situation Just Got a Lot More Crazy
Nevada Woman Accused of Running Fake Business to Traffic SNAP Benefits
Florida Man Causes Delay to Players Championship For Wacky Escape After Double Homicide
Romanian-Linked Theft Ring Accused of Draining $4M From CA Public Assistance Accounts
Trump Announces Build Up of War Ships in the Strait of Hormuz
The Congressman the Left Hates the Most Just Announced a Major Immigration Reform...
The Road to Tehran Runs Through Baku
The Parent-Led Rebellion Against EdTech
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’
AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos